Enzymatic diagnosis and clinical characteristics of 52 children with mucopolysaccharidosis

Chinese Journal of Contemporary Pediatrics

Volumn 14, Issue 7, 2012, Pages 510-514

  Huang, Yong Lan ^a   Li, She Yong ^a   Zhao, Xiao Yuan ^a   Fan, Li Ping ^a   Lin, Wen Chun ^a   Zhou, Zhi Hong ^a   Cheng, Jing ^a   Liu, Li ^a  

^a GUANGZHOU WOMEN AND CHILDREN S MEDICAL CENTER   (China)

Author keywords

Child; Enzymatic assay; Mucopolysaccharidosis; Urinary glycosaminoglycans

Indexed keywords

ALPHA N ACETYLGLUCOSAMINIDASE; BETA GALACTOSIDASE; BETA GLUCURONIDASE; GLYCOSAMINOGLYCAN; IDURONATE 2 SULFATASE; LEVO IDURONIDASE; N ACETYLGALACTOSAMINE 4 SULFATASE; N ACETYLGALACTOSAMINE 6 SULFATASE; ACETYLGLUCOSAMINIDASE; ALPHA N ACETYL D GLUCOSAMINIDASE; ALPHA-N-ACETYL-D-GLUCOSAMINIDASE; CREATININE;

ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME ANALYSIS; ENZYME ELECTROPHORESIS; FLUORESCENCE ANALYSIS; HUMAN; HUNTER SYNDROME; MAJOR CLINICAL STUDY; MORQUIO SYNDROME; MUCOPOLYSACCHARIDOSIS; PRESCHOOL CHILD; PREVALENCE; QUANTITATIVE ANALYSIS; BLOOD; ENZYMOLOGY; FEMALE; INFANT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; URINE;

ACETYLGLUCOSAMINIDASE; BETA-GALACTOSIDASE; CHILD; CHILD, PRESCHOOL; CREATININE; FEMALE; GLUCURONIDASE; GLYCOSAMINOGLYCANS; HUMANS; IDURONIDASE; INFANT; MAGNETIC RESONANCE IMAGING; MALE; MUCOPOLYSACCHARIDOSES;

EID: 84867890916     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Beesley CE, Meaney CA, Greenland G, Adams V, Vellodi A, Young EP, et al. Mutational analysis of 85 mucopelysaccharidosis type I familles: frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations[J]. Hum Genet, 2001, 109(5):503-511.
2. Voznyi YV, Keulemans JL, van Diggelen OP. A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease)[J]. J Inherit Metab Dis, 2001, 24(6):675-680.
3. Kleijer WJ, Geilen GC, Garritsen V, Huijmans JG, Los FJ, Voznyi YV, et al. First-trimester diagnosis of Morquio disease type A[J]. Prenat Diagn, 2000, 20(3):183-185.
4. Iwasaki H, Watanabe H, Iida M, Ogawa S, Tabe M, Higaki K, et al. Fibroblast screening for chaperone therapy in beta-galactnsidosis[J]. Brain Dev, 2006, 28(8):482-486.
5. Chamoles NA, Blanco MB, Gaggioli D, Casentini C. Hurler-like phenotype: Enzymatic diagnosis in dried blood spots on filter paper[J]. Clin Chem, 2001, 47(12):2098-2102.
6. Vervoort R, Gitzelmann R, Bosshard N, Maire I, Liebaers I, Lissens W. Low beta-glucuronidase enzyme activity and mutations in the human beta-glucuronidase gene in mild mucopolysaccharidosis type VII, pseudodeficiency and a heterozygote[J]. Hum Genet, 1998, 102(1):69-78.
7. Marsh J, Fensom AH. 4-Methylumbelliferyl alpha-N-acetylglucosaminidase activity for diagnosis of Sanfilippo B disease[J]. Clin Genet, 1985, 27(3):258-262.
8. Lin HY, Lin SP, Chuang CK, Niu DM, Chen MR, Tsai FJ, et al. Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004[J]. Am J Med Genet A, 2009, 149A(5):960-964.
9. Baehner F, Schmiedeskamp C, Krummenauer F, Miebach E, Bajbouj M, Whybra C, et al. Cumulative incidence rates of the mucopolysaccharidoses in Germany[J]. J Inherit Metab Dis, 2005, 28(6):1011-1017.
10. Coelho JC, Wajner M, Burin MG, Vargas CR, Giugliani R. Selective screening of 10,000 high-risk Brazilian patients for the detection of inborn errors of metabolism[J]. Eur J Pediatr, 1997, 156(8):650-654.
11. Nelson J, Crowhurst J, Carey B, Greed L. Incidence of the mucopolysaccharidoses in Western Australia[J]. Am J Med Genet A, 2003, 123A(3):310-313.
12. Alonso-Fernández JR, Fidalgo J, Colon C. Neonatal screening for mucopolysaccharidoses by determination of glycosaminoglycans in the eluate of urine-impregnated paper: preliminary results of an improved DMB-based procedure[J]. J Clin Lab Anal, 2010, 24(3):149-153.
13. da Silva EM, Strufaldi MW, Andriolo RB, Silva LA. Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)[J]. Cochrane Database Syst Rev, 2011, (11):CD008185.
14. Montaño AM, Tomatsu S, Gottesman GS, Smith M, Orii T. International Morquio A Registry: clinical manifestation and natural course of Morquio A disease[J]. J Inherit Metab Dis, 2007, 30(2):165-174.
15. Nelson J, Thomas PS. Clinical findings in 12 patients with MPS IV A (Morquio's disease). Further evidence for heterogeneity. Part III: Odontoid dysplasia [J]. Clin Genet, 1988, 33(2):126-130.
16. Ransford AO, Crockard HA, Stevens JM, Modaghegh S. Occipitoatlanto-axial fusion in Morquio-Brailsford syndrome. A ten-year experience[J]. J Bone Joint Surg Br, 1996, 78(2):307-313.
17. John A, Fagondes S, Schwartz I, Azevedo AC, Barrios P, Dalcin P, et al. Sleep abnormalities in untreated patients with mucopolysaccharidosis type VI[J]. Am J Med Genet A, 2011, 155A(7):1546-1551.
18. Schwartz IV, Ribeiro MG, Mota JG, Toralles MB, Correia P, Horovitz D, et al. A clinical study of 77 patients with mucopolysaccharidosis type II[J]. Acta Paediatr Suppl, 2007, 96(455):63-70.
19. Sohn YB, Choi EW, Kim SJ, Park SW, Kim SH, Cho SY, et al. Retrospective analysis of the clinical manifestations and survival of Korean patients with mucopolysaccharidosis type II: Emphasis on the cardiovascular complication and mortality cases[J]. Am J Med Genet A, 2011, doi: 10.1002/ajmg.a.34371 [Epub ahead of print].
20. Scarpa M, Almássy Z, Beck M, Bodamer O, Bruce IA, De Meirleir L, et al. Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease[J]. Orphanet J Rare Dis, 2011, 6:72.